📰 Andreaf Wainer News
Page 37 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
January 21, 2024
Lmcg Investments LLC cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 129,777 shares of the healthcare product maker’s stock after selling 2,323 shares during the period. Abbott […]
January 19, 2024
Empirical Finance LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,817 shares of the healthcare product maker’s stock after buying an additional 5,809 shares during the period. Empirical Finance […]
January 19, 2024
Gilbert & Cook Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,436 shares of the healthcare product maker’s stock after selling 1,050 shares during the quarter. Gilbert […]
January 19, 2024
Pittenger & Anderson Inc. lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 69,050 shares of the healthcare product maker’s stock after selling 1,000 shares during the period. […]
January 19, 2024
Novare Capital Management LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 97,695 shares of the healthcare product maker’s stock after purchasing an additional 2,034 shares during the period. Novare Capital Management LLC’s […]
January 18, 2024
Daiwa Securities Group Inc. lifted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 151,926 shares of the healthcare product maker’s stock after buying an additional 10,820 shares during the period. Daiwa […]
January 18, 2024
Csenge Advisory Group lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,631 shares of the healthcare product maker’s stock after selling 1,099 shares during the period. […]
January 18, 2024
FDx Advisors Inc. cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 52.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 56,793 shares of the healthcare product maker’s stock after selling 62,580 shares during the quarter. FDx Advisors Inc.’s holdings […]
January 17, 2024
Abbott Laboratories (NYSE:ABT – Get Free Report) will post its quarterly earnings results before the market opens on Wednesday, January 24th. Analysts expect Abbott Laboratories to post earnings of $1.19 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link. Abbott Laboratories (NYSE:ABT – […]
January 17, 2024
Confluence Wealth Services Inc. lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.2% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 10,675 shares of the healthcare product maker’s stock after buying an additional 529 shares during the quarter. Confluence Wealth Services Inc.’s holdings in Abbott Laboratories were worth […]